Search

everythinglearnresearchcommunity

for

Search:↓

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Erianin may effectively treat alopecia areata by targeting the immune system.

Astressin-B can reverse and prevent hair loss in stressed mice.

Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Ageratum conyzoides extract promotes hair growth and regrowth.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

Vasodilators may worsen abdominal aortic aneurysm.

Upadacitinib improved multiple immune-related conditions in one patient.

Arginine converts to citrulline in hair follicles as proteins harden.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

Stem cell factor and certain proteins help melanocytes from hair follicles move and attach better, aiding vitiligo repigmentation.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

Type 3 acromegaly patients have more health issues and higher death risk.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

Patients with thyroid disorders show different symptoms and antibody levels.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.